Long-term debt consists of the following:


	March 31, 2022			September 30, 2021
Series B term loan	$	996.8		$	1,001.7
Receivables financing agreement		202.4			150.4
Revolving Credit Agreement	$	80.0		$	—
Financing costs, net		(9.5	)		(11.1	)
Total debt, net		1,269.7			1,141.0
Less: Current portion of long-term debt		10.4			10.4
Long-term debt, net	$	1,259.3		$	1,130.6

In connection with the KKR Acquisition, the Company and a group of financial institutions entered into a credit agreement (the “Credit Agreement”) dated December 18, 2013. The Credit Agreement consisted of seven-year $1,460.0 term loans (“First Lien Term Loans”) and a five-year $210.0 revolving credit facility. All amounts outstanding under the Credit Agreement were collateralized by substantially all of the assets of the Company.

On August 15, 2018, the Company entered into Amendment No. 5 to the Credit Agreement (the “Amended Credit Agreement”). Under the terms of the Amended Credit Agreement, the Credit Agreement was amended to provide for: (i) a $1,037.0 seven-year term loan (the “Series B Term Loan”) and (ii) a $260.0 five-year revolving credit facility. The Series B Term Loan matures on August 15, 2025 and bears interest at a rate per annum of LIBOR, plus 2.5%. The Company used the net proceeds from the Series B Term Loan to repay all amounts outstanding under the Company’s First Lien Term Loans. An original discount of $2.8 was incurred when the Series B Term Loan was issued and is being amortized using the effective interest method over the life of the debt, resulting in an effective yield of 2.5%. Debt repayments for the Series B Term Loan consisted of contractual payments per the Credit Agreement and totaled $5.2 for the six month periods ended March 31, 2022 and 2021.

The Company has a five-year $260.0 revolving credit facility (the “Revolving Credit Facility”) that matures on August 15, 2023 and bears interest at a rate per annum of LIBOR plus a margin ranging from 2.00% to 2.50%, with the margin determined based on the Company’s first lien net leverage ratio. The Revolving Credit Facility replaced the previous $210.0 revolving credit facility under the Credit Agreement. During the six months ended March 31, 2022 the Company borrowed $80.0 against the capacity. There were no borrowings or repayments under the facility for the six months ended March 31, 2021.

On April 28, 2017, the Company, through a wholly-owned subsidiary, entered into a receivables financing agreement (the “Receivables Financing Agreement”). The Receivables Financing Agreement provided a borrowing capacity of $175.0 through April 27, 2020. On February 21, 2019, the Company entered into the First Amendment to the Receivables Financing Agreement (the "Amendment Agreement") which increased the borrowing capacity to $200.0 and extended the term through February 20, 2022. On February 19, 2021, the Company entered into the Second Amendment to the Receivables Financing Agreement (the "Second Amendment") which extended the term through February 20, 2024 and increased the borrowing capacity to $235.0 through September 20, 2021 and $250.0 thereafter. All amounts outstanding under the Receivables Financing Agreement are collateralized by substantially all of the accounts receivable and unbilled revenue of the Company. During the six months ended March 31, 2022 the Company borrowed $147.0 against the capacity and voluntarily repaid $95.0. During the six months ended March 31, 2021 the Company borrowed $24.5 against the capacity and voluntarily repaid $24.6.

The following are the scheduled maturities of long-term debt for the remainder of fiscal 2022 and the following five fiscal years and thereafter, which do not include any estimated excess cash flow payments:



2022	$	5.2
2023		90.4
2024		212.8
2025		972.2
2026 and thereafter		—
Total long-term debt		1,280.6
Less: Current maturities		10.4
Less: Original issue discount		1.4
Less: Financing costs		9.5
Total long-term debt, net	$	1,259.3

The Company has estimated the fair value of its long-term debt to be approximately $1,191.8 and $1,148.7 as of March 31, 2022 and September 30, 2021, respectively. Fair value is based on market bid prices around period-end (Level 2 inputs).